Merck Valuation
| 6MK Stock | EUR 103.20 0.20 0.19% |
At this time, the firm appears to be undervalued. Merck secures a last-minute Real Value of €113.32 per share. The latest price of the firm is €103.2. Our model forecasts the value of Merck from analyzing the firm fundamentals such as Price To Sales of 4.69 X, current valuation of 276.64 B, and EBITDA of 18.28 B as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.8178 | Enterprise Value 276.6 B | Enterprise Value Ebitda 14.7371 | Price Sales 4.6867 | Forward PE 23.6407 |
Undervalued
Today
Please note that Merck's price fluctuation is very steady at this time. Calculation of the real value of Merck is based on 3 months time horizon. Increasing Merck's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Merck is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Merck Stock. However, Merck's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 103.2 | Real 113.32 | Hype 103.75 |
The real value of Merck Stock, also known as its intrinsic value, is the underlying worth of Merck Company, which is reflected in its stock price. It is based on Merck's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Merck's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Merck Co helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck more accurately as focusing exclusively on Merck's fundamentals will not take into account other important factors: Merck Cash |
|
About Merck Valuation
The stock valuation mechanism determines Merck's current worth on a weekly basis. Our valuation model uses a comparative analysis of Merck. We calculate exposure to Merck's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 56.3 B | 40.8 B |
Merck Quarterly Retained Earnings |
|
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |